Costello, Ph.D., a former postdoctoral fellow on Collins team whos now an Instructor of Medicine at Harvard Medical School
At peak, compounded GLP-1 medications accounted for roughly 30% of US supply, according to published industry estimates, at prices of $150 to $300 per month versus $1,000-plus for brand-name versions
To be clear, GLP-1s are not FDA-approved for treating these conditions right now, but if more research proves they are safe and effective, they could receive formal approval for these uses (or others) in the future
Maybe, but you might not as well
Muscle Preservation & Recovery BPC-157 for Recovery Tissue repair support during deficits
Losing more than a pound per week consistently can increase your risk of muscle loss